Key findings included 94% of test-phase responders experienced at least a 50% decrease in episodes of UUI.
Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...